Erste Asset Management Gmb H Xencor Inc Transaction History

Erste Asset Management Gmb H

  • $7.79 Trillion
  • Q1 2025

A detailed history of Erste Asset Management Gmb H transactions in Xencor Inc stock. As of the latest transaction made, Erste Asset Management Gmb H holds 380,200 shares of XNCR stock, worth $4.08 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
380,200
Previous 352,200 7.95%
Holding current value
$4.08 Million
Previous $8.37 Billion 51.44%
% of portfolio
0.05%
Previous 0.1%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$10.64 - $24.13 $297,920 - $675,640
28,000 Added 7.95%
380,200 $4.06 Billion
Q3 2024

Nov 14, 2024
BUY
$15.7 - $21.65 $5.53 Million - $7.63 Million
352,200 New
352,200 $7.09 Billion
Q4 2023

Nov 26, 2024
BUY
$16.53 - $21.42 $1.82 Million - $2.36 Million
110,000 Added 49.06%
334,200 $7.1 Billion
Q3 2023

Nov 26, 2024
BUY
$20.08 - $25.39 $240,959 - $304,680
12,000 Added 5.66%
224,200 $4.53 Billion
Q2 2023

Nov 26, 2024
BUY
$24.77 - $29.9 $297,240 - $358,800
12,000 Added 5.66%
224,200 $5.61 Billion
Q1 2023

Nov 26, 2024
BUY
$25.95 - $36.95 $1.04 Million - $1.48 Million
40,000 Added 23.23%
212,200 $5.9 Billion
Q4 2022

Nov 26, 2024
BUY
$24.79 - $30.86 $991,600 - $1.23 Million
40,000 Added 23.23%
212,200 $5.51 Billion
Q3 2022

Nov 26, 2024
SELL
$24.62 - $32.44 $4.43 Million - $5.84 Million
-180,000 Reduced 51.11%
172,200 $4.46 Billion
Q2 2022

Nov 26, 2024
BUY
$19.74 - $29.01 $473,759 - $696,240
24,000 Added 16.19%
172,200 $4.71 Billion
Q1 2022

Nov 22, 2024
BUY
$26.68 - $41.63 $266,800 - $416,300
10,000 Added 6.17%
172,200 $4.62 Billion
Q4 2021

Nov 22, 2024
SELL
$33.67 - $43.44 $6.06 Million - $7.82 Million
-180,000 Reduced 51.11%
172,200 $7.02 Billion
Q3 2021

Nov 22, 2024
BUY
$30.65 - $35.68 $521,050 - $606,560
17,000 Added 11.71%
162,200 $5.28 Billion
Q2 2021

Nov 22, 2024
BUY
$34.33 - $44.68 $377,630 - $491,480
11,000 Added 8.2%
145,200 $5 Billion
Q3 2020

Nov 22, 2024
SELL
$30.09 - $43.02 $6.56 Million - $9.38 Million
-218,000 Reduced 61.9%
134,200 $5.22 Billion
Q2 2020

Nov 22, 2024
BUY
$27.76 - $33.42 $138,800 - $167,100
5,000 Added 3.87%
134,200 $4.34 Billion
Q1 2020

Nov 22, 2024
SELL
$20.69 - $37.79 $517,250 - $944,750
-25,000 Reduced 16.21%
129,200 $3.88 Billion
Q4 2019

Nov 22, 2024
SELL
$32.75 - $41.43 $6.48 Million - $8.2 Million
-198,000 Reduced 56.22%
154,200 $5.3 Billion
Q1 2019

Nov 22, 2024
SELL
$27.85 - $38.09 $5.51 Million - $7.54 Million
-198,000 Reduced 56.22%
154,200 $4.83 Billion
Q4 2018

Nov 26, 2024
SELL
$32.39 - $42.05 $6.61 Million - $8.58 Million
-204,000 Reduced 57.92%
148,200 $5.14 Billion

Others Institutions Holding XNCR

# of Institutions
213
Shares Held
76.2M
Call Options Held
1.7K
Put Options Held
4.2K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $640M
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email